Heart Protection In large-scale clinical trials like LEADER, GLP-1s were shown to lower the risk of heart attack, stroke, and cardiovascular death
Common symptoms include chronic diarrhoea, abdominal pain, bloating, fatigue, and weight loss, though some individuals may present with atypical symptoms such as anaemia, osteoporosis, or neurological manifestations
Phentermine and Vyvanse drug warnings Patients who should not use Vyvanse include those who have preexisting heart conditions like high blood pressure (since it can cause cardiovascular reactions), a medical history of substance abuse, hypersensitivity to amphetamines, or those who have taken an MAOI within 14 days
Regulates appetite and blood sugar with a once-weekly injection